Suedharz Klinikum Nordhausen gGmbH

At Suedharz Klinikum Nordhausen gGmbH, clinical trials focus on neoplasms with a strong emphasis on breast cancer. The research explores new treatment options for people with early and high-risk disease, including ER+/HER2- breast cancer, HER2-negative breast cancer, and other forms of early breast cancer.

• Testing whether adding new immunotherapy or targeted treatment approaches can improve outcomes in triple-negative breast cancer
• Evaluating treatments that may reduce the risk of recurrence in high-risk early breast cancer
• Studying better ways to support long-term disease control after standard treatment

The site’s work is centered on improving survival, lowering relapse risk, and refining treatment choices for patients with HER2-negative and hormone receptor-positive breast cancers.

Clinical research at this hospital in Nordhausen includes studies in early breast cancer that compare different treatment approaches for patients at intermediate or high risk of recurrence. These trials are designed to help determine which therapies may offer the best balance of effectiveness and long-term disease control.

• Comparing endocrine therapy with additional targeted treatment versus standard chemotherapy
• Assessing whether personalized treatment can improve invasive disease-free survival
• Exploring options for patients with HR+/HER2- early breast cancer

This research aims to support more tailored care for patients diagnosed with early-stage disease, especially those who may benefit from treatment beyond standard approaches.

The trial portfolio also includes studies of adjuvant treatment and targeted therapies for HER2-negative breast cancer. These investigations look at whether adding newer medicines after initial therapy can help prevent the cancer from returning and improve disease-free survival.

• Examining targeted treatment for patients with germline BRCA-mutated breast cancer
• Assessing the value of PARP inhibitor-based therapy in the adjuvant setting
• Comparing treatment effectiveness in patients with higher relapse risk after standard care

Overall, the research at MVZ Nordhausen is aimed at improving post-surgery treatment decisions and identifying therapies that may better protect patients from recurrence.